Breast tumors are classified by the presence of three molecular markers: estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), that allow targeted therapy beside chemotherapy [2]. The gene discussed is ESR1; the disease is breast neoplasm.